Alberto Fernández1, Vicent Hernández2, David Martínez-Ares3, Luciano Sanromán2, María Luisa de Castro2, Juan Ramón Pineda4, Amalia Carmona5, Carlos González-Portela5, Carlos Salgado6, Jesús Martínez-Cadilla2, Santos Pereira2, Jose Ignacio García-Burriel7, Santiago Vázquez5, Ignacio Rodríguez-Prada2. 1. Servicio de Aparato Digestivo, Hospital POVISA, Vigo, Spain. Electronic address: afvillaverde@gmail.com. 2. Servicio de Aparato Digestivo, Complexo Hospitalario Universitario de Vigo, Spain; 'IBIV' Institute of Biomedical Research of Vigo, Vigo, Spain. 3. Servicio de Aparato Digestivo, Complexo Hospitalario Universitario de Vigo, Spain; 'IBIV' Institute of Biomedical Research of Vigo, Vigo, Spain; Hospital Perpetuo Socorro, Vigo, Spain. 4. Servicio de Aparato Digestivo, Complexo Hospitalario Universitario de Vigo, Spain; 'IBIV' Institute of Biomedical Research of Vigo, Vigo, Spain; Hospital Fátima, Vigo, Spain. 5. Servicio de Aparato Digestivo, Hospital POVISA, Vigo, Spain. 6. Servicio de Aparato Digestivo, Complexo Hospitalario Universitario de Vigo, Spain. 7. Servicio de Pediatria, Complexo Hospitalario Universitario de Vigo, Spain.
Abstract
INTRODUCTION: Incidence of inflammatory bowel disease (IBD) is increasing progressively. Few recent epidemiological prospective studies are available in Spain. The Epicom study, a population-based inception cohort of unselected IBD patients developed within the European Crohn's and Colitis Organization, was started in 2010. Vigo is the only Spanish area participating. OBJECTIVE: To describe the incidence of IBD in the Vigo area and the phenotypical characteristics at diagnosis and to compare them with previous data available in Spain. MATERIAL AND METHODS: Epidemiological, descriptive, prospective, and population-based study. All incident cases of IBD during 2010 and living in the Vigo area at diagnosis were included. The Copenhagen Diagnostic criteria were used to define cases. Background population at the start of the study was 579,632 inhabitants. Data were prospectively entered in the EpiCom database. RESULTS: A total of 106 patients were included (57.5% men, median age 39.5 years). Of them 53 were diagnosed of as Crohn's disease (CD), 47 ulcerative colitis (UC) and six IBD unclassified (IBDU). The incidence rate per 100,000 per year for patients aged 15 years or older was 21.4 (10.8 for CD, 9.4 for UC, 1.2 IBDU). Including pediatric population incidence rates were 18.3 (10.3 CD, 8.7 UC, 1.2 IBDU). Median time since onset of symptoms until diagnosis was 2 months. CONCLUSIONS: The incidence rate of IBD in Vigo is the highest compared to former Spanish cohorts, especially in CD patients. Median time since onset of symptoms until diagnosis is relatively short.
INTRODUCTION: Incidence of inflammatory bowel disease (IBD) is increasing progressively. Few recent epidemiological prospective studies are available in Spain. The Epicom study, a population-based inception cohort of unselected IBD patients developed within the European Crohn's and Colitis Organization, was started in 2010. Vigo is the only Spanish area participating. OBJECTIVE: To describe the incidence of IBD in the Vigo area and the phenotypical characteristics at diagnosis and to compare them with previous data available in Spain. MATERIAL AND METHODS: Epidemiological, descriptive, prospective, and population-based study. All incident cases of IBD during 2010 and living in the Vigo area at diagnosis were included. The Copenhagen Diagnostic criteria were used to define cases. Background population at the start of the study was 579,632 inhabitants. Data were prospectively entered in the EpiCom database. RESULTS: A total of 106 patients were included (57.5% men, median age 39.5 years). Of them 53 were diagnosed of as Crohn's disease (CD), 47 ulcerative colitis (UC) and six IBD unclassified (IBDU). The incidence rate per 100,000 per year for patients aged 15 years or older was 21.4 (10.8 for CD, 9.4 for UC, 1.2 IBDU). Including pediatric population incidence rates were 18.3 (10.3 CD, 8.7 UC, 1.2 IBDU). Median time since onset of symptoms until diagnosis was 2 months. CONCLUSIONS: The incidence rate of IBD in Vigo is the highest compared to former Spanish cohorts, especially in CD patients. Median time since onset of symptoms until diagnosis is relatively short.
Authors: Javier Molina-Infante; Pedro Luis Gonzalez-Cordero; Hal Cliff Ferreira-Nossa; Pilar Mata-Romero; Alfredo J Lucendo; Angel Arias Journal: United European Gastroenterol J Date: 2017-04-21 Impact factor: 4.623
Authors: María Chaparro; Manuel Barreiro-de Acosta; José Manuel Benítez; José Luis Cabriada; María José Casanova; Daniel Ceballos; María Esteve; Hipólito Fernández; Daniel Ginard; Fernando Gomollón; Rufo Lorente; Pilar Nos; Sabino Riestra; Montserrat Rivero; Pilar Robledo; Cristina Rodríguez; Beatriz Sicilia; Emilio Torrella; Ana Garre; Esther García-Esquinas; Fernando Rodríguez-Artalejo; Javier P Gisbert Journal: Therap Adv Gastroenterol Date: 2019-05-21 Impact factor: 4.409
Authors: Jae Young Choe; Sujin Choi; Ki Hwan Song; Hyo-Jeong Jang; Kwang-Hae Choi; Dae Yong Yi; Suk Jin Hong; Jun Hyun Hwang; Seung-Man Cho; Young Jin Kim; Byung-Ho Choe; Ben Kang Journal: Front Pediatr Date: 2022-01-04 Impact factor: 3.418